Merck’s Stock Dip Offers a Buying Opportunity: Here’s Why
MRK Merck & Co., Inc. $114.48 +0.81 (+0.71%) (As of 08/19/2024 ET) 52-Week Range $99.14 ▼ $134.63 Dividend Yield 2.69% P/E Ratio 127.20 Price Target $134.58 Global big pharmaceutical company Merck & Co. Inc. NYSE: MRK shares sank 9% following its Q2 2024 earnings release. Merck beat top and bottom line estimates, but the lowered full-year…
